CSIMarket


Coeptis Therapeutics Holdings Inc   (COEP)
Other Ticker:  
 

Coeptis Therapeutics Holdings Inc

COEP's Fundamental analysis








Coeptis Therapeutics Holdings Inc 's sales fell in III. Quarter 2023 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -7.98 %



More on COEP's Growth


Coeptis Therapeutics Holdings Inc
realized net loss in trailing twelve months.

Company
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.65.


More on COEP's Valuation
 
 Total Debt (Millions $) 1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Coeptis Therapeutics Holdings Inc
realized net loss in trailing twelve months.

Company
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.65.